Market News

AngioDynamics, Inc. (ANGO) Reaches $20.20 52-Week High; Stevens Capital Management LP Has Lowered By $1.64 Million Its Nuance Communications (NUAN) Stake

Nuance Communications, Inc. (NASDAQ:NUAN) Logo

The stock of AngioDynamics, Inc. (NASDAQ:ANGO) hit a new 52-week high and has $21.01 target or 4.00% above today’s $20.20 share price. The 9 months bullish chart indicates low risk for the $743.64M company. The 1-year high was reported on Apr, 16 by Barchart.com. If the $21.01 price target is reached, the company will be worth $29.75M more. The stock increased 2.15% or $0.42 during the last trading session, reaching $20.2. About 64,919 shares traded. AngioDynamics, Inc. (NASDAQ:ANGO) has declined 2.41% since April 16, 2017 and is downtrending. It has underperformed by 13.96% the S&P500.

Stevens Capital Management Lp decreased Nuance Communications Inc (NUAN) stake by 35.34% reported in 2017Q4 SEC filing. Stevens Capital Management Lp sold 102,255 shares as Nuance Communications Inc (NUAN)’s stock declined 6.16%. The Stevens Capital Management Lp holds 187,124 shares with $3.06M value, down from 289,379 last quarter. Nuance Communications Inc now has $4.46B valuation. The stock increased 2.02% or $0.3 during the last trading session, reaching $15.18. About 418,209 shares traded. Nuance Communications, Inc. (NASDAQ:NUAN) has declined 7.39% since April 16, 2017 and is downtrending. It has underperformed by 18.94% the S&P500.

AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices for the treatment of peripheral vascular disease, vascular access, and for use in oncology and surgical settings in the United States and internationally. The company has market cap of $743.64 million. The firm provides manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers, and interventional accessories that help clinicians in the diagnosis and treatment of cardiovascular and peripheral vascular diseases; VenaCure EVLT laser system products to treat superficial venous diseases; Asclera drug for treating uncomplicated spider and reticular veins of the lower extremities; and Sotradecol drugs for treating small uncomplicated varicose veins of the lower extremities. It has a 561.25 P/E ratio. It also offers AngioVac venous drainage system that includes venous drainage cannula for the removal of fresh, soft thrombi, or emboli during extracorporeal bypass; and cardiopulmonary bypass circuit for use in procedures during extracorporeal circulatory support.

Investors sentiment increased to 1.26 in Q4 2017. Its up 0.09, from 1.17 in 2017Q3. It improved, as 14 investors sold AngioDynamics, Inc. shares while 48 reduced holdings. 22 funds opened positions while 56 raised stakes. 33.90 million shares or 1.62% more from 33.36 million shares in 2017Q3 were reported. Fuller & Thaler Asset accumulated 525 shares. Tiaa Cref Invest Mngmt Ltd Llc accumulated 251,040 shares or 0% of the stock. Wellington Mngmt Gp Llp holds 0% in AngioDynamics, Inc. (NASDAQ:ANGO) or 11,650 shares. Alliancebernstein Ltd Partnership accumulated 0% or 169,910 shares. Voya Invest Mngmt reported 0% stake. Envestnet Asset Mngmt holds 0% of its portfolio in AngioDynamics, Inc. (NASDAQ:ANGO) for 3,980 shares. Wells Fargo And Mn has invested 0.01% in AngioDynamics, Inc. (NASDAQ:ANGO). Bancorporation Of America De holds 75,286 shares. Meeder Asset Management has invested 0% in AngioDynamics, Inc. (NASDAQ:ANGO). Thomson Horstmann & Bryant Incorporated holds 369,308 shares. Bridgeway Management Inc holds 0.02% or 138,100 shares. Intll Gp invested 0% of its portfolio in AngioDynamics, Inc. (NASDAQ:ANGO). Laurion Cap Mngmt L P holds 18,300 shares or 0% of its portfolio. State Of Tennessee Treasury Department owns 25,069 shares. 600,000 are owned by Fmr Lc.

Among 8 analysts covering AngioDynamics (NASDAQ:ANGO), 2 have Buy rating, 0 Sell and 6 Hold. Therefore 25% are positive. AngioDynamics has $17 highest and $14.5 lowest target. $15.83’s average target is -21.63% below currents $20.2 stock price. AngioDynamics had 23 analyst reports since July 24, 2015 according to SRatingsIntel. The rating was maintained by Canaccord Genuity with “Hold” on Tuesday, July 18. On Monday, August 31 the stock rating was upgraded by Zacks to “Sell”. The stock of AngioDynamics, Inc. (NASDAQ:ANGO) has “Hold” rating given on Thursday, March 29 by Canaccord Genuity. The company was maintained on Wednesday, May 31 by Canaccord Genuity. The firm has “Outperform” rating given on Tuesday, April 3 by Raymond James. The rating was maintained by KeyBanc Capital Markets with “Hold” on Thursday, August 24. Barclays Capital maintained it with “Equal-Weight” rating and $16 target in Wednesday, July 19 report. KeyBanc Capital Markets maintained the stock with “Hold” rating in Thursday, September 28 report. Craig Hallum downgraded the shares of ANGO in report on Friday, January 5 to “Hold” rating. As per Sunday, August 6, the company rating was maintained by Canaccord Genuity.

Analysts await Nuance Communications, Inc. (NASDAQ:NUAN) to report earnings on May, 8. They expect $0.17 EPS, down 46.88% or $0.15 from last year’s $0.32 per share. NUAN’s profit will be $49.92 million for 22.32 P/E if the $0.17 EPS becomes a reality. After $0.19 actual EPS reported by Nuance Communications, Inc. for the previous quarter, Wall Street now forecasts -10.53% negative EPS growth.

Stevens Capital Management Lp increased Antero Res Corp (NYSE:AR) stake by 49,713 shares to 164,205 valued at $3.12 million in 2017Q4. It also upped Jazz Pharmaceuticals Plc (NASDAQ:JAZZ) stake by 36,126 shares and now owns 37,805 shares. Allergan Plc was raised too.

Among 11 analysts covering Nuance Communications (NASDAQ:NUAN), 9 have Buy rating, 0 Sell and 2 Hold. Therefore 82% are positive. Nuance Communications had 36 analyst reports since August 7, 2015 according to SRatingsIntel. As per Friday, August 7, the company rating was maintained by FBR Capital. As per Wednesday, November 29, the company rating was maintained by Raymond James. Stifel Nicolaus maintained Nuance Communications, Inc. (NASDAQ:NUAN) on Tuesday, August 8 with “Hold” rating. As per Friday, February 9, the company rating was maintained by Oppenheimer. Barclays Capital maintained Nuance Communications, Inc. (NASDAQ:NUAN) on Wednesday, August 9 with “Overweight” rating. The firm earned “Buy” rating on Monday, January 18 by Standpoint Research. The stock of Nuance Communications, Inc. (NASDAQ:NUAN) earned “Buy” rating by Canaccord Genuity on Wednesday, August 9. The firm earned “Buy” rating on Wednesday, August 9 by Deutsche Bank. The stock of Nuance Communications, Inc. (NASDAQ:NUAN) earned “Outperform” rating by Leerink Swann on Wednesday, May 11. The company was maintained on Tuesday, August 9 by Deutsche Bank.

Investors sentiment decreased to 0.88 in 2017 Q4. Its down 0.07, from 0.95 in 2017Q3. It fall, as 75 investors sold NUAN shares while 88 reduced holdings. 62 funds opened positions while 82 raised stakes. 233.98 million shares or 15.90% more from 201.88 million shares in 2017Q3 were reported. Dimensional Fund Advsrs L P, a Texas-based fund reported 2.38 million shares. Goldman Sachs Gp has invested 0% in Nuance Communications, Inc. (NASDAQ:NUAN). Manufacturers Life Communication The holds 0% of its portfolio in Nuance Communications, Inc. (NASDAQ:NUAN) for 9,212 shares. Moreover, Brant Point Investment Mngmt Ltd Llc has 0.87% invested in Nuance Communications, Inc. (NASDAQ:NUAN) for 523,879 shares. Carnegie Capital Asset Mngmt Limited Liability Company holds 0.02% of its portfolio in Nuance Communications, Inc. (NASDAQ:NUAN) for 14,342 shares. Vident Advisory Ltd Liability Corp has invested 0.87% of its portfolio in Nuance Communications, Inc. (NASDAQ:NUAN). State Board Of Administration Of Florida Retirement Systems invested 0.02% of its portfolio in Nuance Communications, Inc. (NASDAQ:NUAN). The Georgia-based Gmt has invested 0.73% in Nuance Communications, Inc. (NASDAQ:NUAN). Creative Planning reported 0% of its portfolio in Nuance Communications, Inc. (NASDAQ:NUAN). Pennsylvania-based Haverford Tru Com has invested 0.01% in Nuance Communications, Inc. (NASDAQ:NUAN). Amalgamated National Bank has 55,060 shares. Aviva Pcl reported 0.01% of its portfolio in Nuance Communications, Inc. (NASDAQ:NUAN). Voya Inv Mgmt Ltd Limited Liability Company reported 0.02% stake. Lapides Asset Mgmt Lc accumulated 406,800 shares. Wealthtrust holds 0.01% of its portfolio in Nuance Communications, Inc. (NASDAQ:NUAN) for 750 shares.

Nuance Communications, Inc. (NASDAQ:NUAN) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *